{"id":"https://openalex.org/W2186952117","doi":null,"title":"SERUM LEVEL OF IL-17, IL-22, IFN- ,1 3$7,(176 :,7+ PSORIASIS","display_name":"SERUM LEVEL OF IL-17, IL-22, IFN- ,1 3$7,(176 :,7+ PSORIASIS","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2186952117","mag":"2186952117"},"language":"en","primary_location":{"id":"mag:2186952117","doi":null,"is_oa":false,"landing_page_url":"http://edoj.org.eg/vol005/0501/004/paper.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2186952117"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044972590","display_name":"Inas Almakhzangy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Inas Almakhzangy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5029897407","display_name":"Ahmed Gaballa","orcid":"https://orcid.org/0000-0002-5277-5129","observed_orcids":["https://orcid.org/0000-0002-5277-5129"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ahmed Gaballa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":1.0},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.9259999990463257},{"id":"https://openalex.org/keywords/il-22","display_name":"IL-22","score":1.0},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9419999718666077},{"id":"https://openalex.org/keywords/th17-cells","display_name":"Th17 cells","score":0.843999981880188},{"id":"https://openalex.org/keywords/th1-cells","display_name":"Th1 cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/serum-cytokines","display_name":"serum cytokines","score":0.8550000190734863},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pasi-score","display_name":"PASI score","score":0.9319999814033508},{"id":"https://openalex.org/keywords/inflammatory-skin-diseases","display_name":"inflammatory skin diseases","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.947777509689331},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.794858455657959},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.6907120943069458},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6248867511749268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6195081472396851},{"id":"https://openalex.org/C156730664","wikidata":"https://www.wikidata.org/wiki/Q23308590","display_name":"Interleukin 23","level":4,"score":0.45910122990608215},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4547708034515381},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.33326247334480286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27450329065322876}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186952117","doi":null,"is_oa":false,"landing_page_url":"http://edoj.org.eg/vol005/0501/004/paper.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1527011538","https://openalex.org/W1545677703","https://openalex.org/W1576903429","https://openalex.org/W1898882018","https://openalex.org/W1899583926","https://openalex.org/W1960035134","https://openalex.org/W1969629598","https://openalex.org/W1976306345","https://openalex.org/W1979058179","https://openalex.org/W1980504592","https://openalex.org/W1993168239","https://openalex.org/W2000076767","https://openalex.org/W2000851235","https://openalex.org/W2004186675","https://openalex.org/W2008351377","https://openalex.org/W2008924149","https://openalex.org/W2012077729","https://openalex.org/W2013488106","https://openalex.org/W2024387258","https://openalex.org/W2038621043","https://openalex.org/W2048891510","https://openalex.org/W2071343804","https://openalex.org/W2074062652","https://openalex.org/W2074205207","https://openalex.org/W2074753880","https://openalex.org/W2080090843","https://openalex.org/W2091451666","https://openalex.org/W2098814367","https://openalex.org/W2139008734","https://openalex.org/W2161432567"],"related_works":["https://openalex.org/W2140878678","https://openalex.org/W2095128503","https://openalex.org/W1541978791","https://openalex.org/W4200433485","https://openalex.org/W2488309603","https://openalex.org/W3032709515","https://openalex.org/W2150501572","https://openalex.org/W3027135752","https://openalex.org/W7218252190"],"abstract_inverted_index":{"Psoriasis":[0],"is":[1,8,122],"a":[2,26,123],"chronic":[3],"inflammatory":[4,128],"skin":[5],"disease":[6,70],"that":[7,35,120],"thought":[9],"to":[10,69,93],"be":[11],"mediated":[12],"by":[13,75],"Th1":[14,125],"cells,":[15],"secreting":[16],"IFN-":[17,54,113],",QWHUHVWLQJO":[18],"UHFHQW":[19],"DGYDQFHV":[20],"E":[21],"FHOOXODU":[22],"LPPXQRORJLVWV":[23],"KDYH":[24],"identified":[25],"new":[27],"distinct":[28],"type":[29],"of":[30,50,84,101],"T-cell,":[31],"called":[32],"Th17":[33,127],"cell":[34],"play":[36],"an":[37],"essential":[38],"pathogenic":[39],"role":[40],"in":[41,55,91],"psoriasis.":[42],"In":[43],"this":[44],"study":[45],"we":[46],"measured":[47],"serum":[48,96,99],"levels":[49,68,83,100],"IL-17,":[51],"IL-22":[52,105],"and":[53,59,104,126],"30":[56,60],"psoriatic":[57],"patients":[58],"healthy":[61],"control":[62,95],"using":[63],"ELISA":[64],"method,":[65],"correlating":[66],"their":[67],"severity,":[71],"which":[72],"was":[73,115],"calculated":[74],"psoriasis":[76,121],"area":[77],"severity":[78],"index":[79],"(PASI)":[80],"score.":[81],"Serum":[82],"the":[85],"studied":[86],"cytokines":[87],"were":[88,106],"significantly":[89,107],"elevated":[90],"comparison":[92],"normal":[94],"levels.":[97],"Also":[98],"both":[102],"IL-17":[103],"correlated":[108],"with":[109],"PASI":[110],"score,":[111],"while":[112],"level":[114],"not.":[116],"Our":[117],"result":[118],"indicating":[119],"mixed":[124],"environment":[129],"disease.":[130]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2186952117","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
